I'm still wondering whether the Novartis - BDD lic
Post# of 72440
Do Novartis and IPIX have a CDA in place that would denote the product as an "undisclosed compound". And with an undisclosed compound agreement and use of Oralogik, Novartis would
be granted the First Right to Negotiate a deal for Bril-UC after Phase 1??